医学
美罗华
内科学
析因分析
队列
胃肠病学
临床试验
肺活量
事后
扩散能力
淋巴瘤
肺
肺功能
作者
Ai Kuzumi,Satoshi Ebata,Takemichi Fukasawa,Kazuki Matsuda,Hirohito Kotani,Asako Yoshizaki‐Ogawa,Shinichi Sato,Ayumi Yoshizaki
出处
期刊:JAMA Dermatology
[American Medical Association]
日期:2023-02-15
卷期号:159 (4): 374-374
被引量:20
标识
DOI:10.1001/jamadermatol.2022.6340
摘要
Rituximab is emerging as a promising therapeutic option for systemic sclerosis (SSc), but its long-term outcomes and response markers are unknown.
科研通智能强力驱动
Strongly Powered by AbleSci AI